We offer comprehensive preformulation solutions designed to assess developability of preclinical lead molecules. Our solid state and formulation expertise address key challenges of lead molecules, such as solubility, stability and bioavailability enabling them to progress to toxicity studies. Our preformulation solutions include salt/cocrystal selection, polymorph selection, novel formulation technologies development like microemulsion, amorphous solid dispersion, nanosuspension, long acting injectable and liposomes.